At what enterprise value was SEBIA acquired in 2017?

During the acquisition of SEBIA by CVC in 2017, the transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR.

What was the EV/EBITDA of SEBIA when it was acquired by CVC?

The estimated EV/EBITDA multiple for SEBIA is in the range of 15x - 25x.

When was SEBIA acquired by CVC?

SEBIA was acquired by CVC in 2017.

What was the EBITDA of SEBIA during the acquisition?

SEBIA's EBITDA is estimated to be in the range of 100M - 200M EUR.

How is the data for the SEBIA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SEBIA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.lesechos.fr/2017/10/la-famille-bettencourt-meyers-sinvite-au-capital-de-la-pepite-sebia-184114

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaSEBIA

10/2017

SEBIA acquired by CVC

FRANCE Life Sciences / Medical Devices / Diagnostic Equipment EV 1b - 4b EUR

Context

CVC and the Canadian company CDPQ are acquiring control of the medical diagnostics specialist Sebia. The company is valued at nearly EUR2 billion, according to multiple sources.

SEBIA, which reported an EBITDA margin of in 2017, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

A global leader in in-vitro diagnostics (IVD), specializing in clinical electrophoresis technology. Founded in 1967, Sebia provides automated equipment and reagents used by medical laboratories worldwide to screen and monitor diseases such as multiple myeloma, metabolic disorders (diabetes), and hemoglobinopathies. The company generates over 90% of its sales internationally and has a direct presence in 15 countries.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2017

2016

Other operations with SEBIA

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
08/2025	WARBURG PINCUS	SEBIA	FRANCE	Diagnostic Equipment

REFERENCES

Valuation range: EV 1b - 4b EUR

EBITDA range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SEBIA by CVC are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: sebia

Acquirer: cvc